#MuscleLoss #Longevity #HealthyAging #Sarcopenia #Metabolism

Muscle loss after age 40 is one of the most overlooked health risks of aging. Most people think aging is about wrinkles or gray hair — but one of the biggest biological changes happening inside the body is the gradual loss of muscle mass and strength.

This condition, known as sarcopenia, can slow metabolism, increase fat gain, reduce strength, and raise the risk of diabetes and cardiovascular disease.

In this video, Dr. Mohammed Paika (Board-Certified in Internal Medicine & Obesity Medicine) explains why muscle loss accelerates after 40, how it affects metabolism and longevity, and what you can do to preserve muscle and stay strong as you age.

Protecting muscle is one of the most important strategies for healthy aging, metabolic health, and long-term independence.

#GLP1 #Ozempic #WeightLossStall #ObesityMedicine #FatLoss

GLP-1 medications like Ozempic, Wegovy, and Zepbound are powerful tools for weight loss — but they don’t work the same for everyone.

Some patients lose significant weight… while others plateau, lose slowly, or feel like the medication isn’t working at all.

In this video, Dr. Mohammed Paika (board-certified in Internal Medicine & Obesity Medicine) explains the real medical reasons GLP-1 weight loss can stall — including dosing, metabolic adaptation, muscle loss, nutrition, and underlying health factors.

If your weight loss has slowed or stopped on GLP-1 therapy, this video will help you understand why — and what actually improves results.

⏱️ TIMESTAMPS

0:00 Why GLP-1 Doesn’t Work the Same for Everyone
0:42 Expectation vs Reality on GLP-1
1:35 Reason 1 — Dose & Duration
2:45 Reason 2 — Metabolic Adaptation
4:05 Reason 3 — Muscle Loss
5:25 Reason 4 — Ultra-Processed Diet
6:40 Reason 5 — Medical Factors
7:55 True Non-Responders
8:35 What Improves GLP-1 Results

⚕️ MEDICAL & EDUCATIONAL DISCLAIMER
This channel and its content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information presented is not intended as medical advice and does not replace consultation with your personal physician or qualified healthcare professional.
Viewing this content does not create a doctor-patient relationship between you and Dr. Paika.
Health, nutrition, exercise, and medication topics discussed on this channel may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.
Exercise and lifestyle changes carry inherent risks. By choosing to follow any information from this channel, you accept full responsibility for your health decisions and outcomes.
Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from use or application of information presented in this content.

#ObesityAndCancer #CancerRisk #ObesityMedicine #WeightLossScience #cancerprevention
#longevity

Obesity is now recognized as a major risk factor for 13 different cancers — including breast, colon, pancreatic, liver, and uterine cancer.

In this video, Dr. Mohammed Paika (board-certified in Internal Medicine & Obesity Medicine) explains the science behind how excess body fat increases cancer risk, which cancers are most strongly linked to obesity, and how weight loss may reduce long-term cancer risk.

You’ll learn the biological mechanisms connecting obesity and cancer, including inflammation, insulin resistance, hormonal changes, and organ fat deposition — all explained in clear, practical terms.

This is not fear-based messaging.
It’s evidence-based medicine.

Understanding this link can help patients, clinicians, and families view obesity treatment not just as weight management — but as disease and cancer prevention.

If you want to understand the real health impact of obesity beyond weight, this is essential knowledge.

TIMESTAMPS
0:00 Obesity & Cancer — The Hidden Link
0:46 The 13 Cancers Linked to Obesity
1:52 Why Obesity-Related Cancers Are Rising
2:40 How Body Fat Promotes Cancer
4:05 Inflammation & Insulin Mechanisms
5:28 Hormones & Estrogen Effects
6:22 Strongest Cancer Links Explained
7:34 Does Weight Loss Reduce Risk?
8:36 Clinical Takeaways & Prevention

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

#Obesity #ProcessedFood #Metabolism #WeightGain #NutritionScience #longevity

Ultra-processed foods now make up the majority of calories in modern diets — and they may be one of the biggest hidden drivers of obesity, metabolic disease, and weight gain.

In this evidence-based lecture, Dr. Mohammed Paika (double board-certified in Internal Medicine & Obesity Medicine) explains how ultra-processed foods alter metabolism, increase calorie intake, promote visceral fat, and disrupt satiety signals.

You’ll learn the science behind why processed foods make it easier to overeat, harder to lose weight, and more likely to develop metabolic disease — even when calories appear similar.

If you want to understand obesity beyond “calories in vs calories out,” this lecture connects nutrition science, metabolism, and the modern food environment.

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

GLP-1 medications like Ozempic, Wegovy, and Zepbound are powerful tools for weight loss — but many patients don’t realize they can also lose muscle if nutrition and training aren’t optimized.

In this video, Dr. Mohammed Paika (board-certified in Internal Medicine & Obesity Medicine) explains how to lose fat while protecting metabolism, strength, and long-term results.

You’ll learn the most common causes of muscle loss on GLP-1s, ideal protein targets, and why strength training is the key signal your body needs during weight loss.

If you want sustainable fat loss — not just weight loss — this is critical.

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

#GLP1SideEffects #OzempicTips #WegovyJourney #WeightLossDoctor #ObesityMedicine

Starting GLP-1 medications like Ozempic, Wegovy, or Zepbound can feel life-changing — but side effects often create fear, confusion, and unnecessary discontinuation.

In this lesson from the GLP-1 Weight Loss Masterclass, Dr. Mohammed Paika — Board-Certified in Internal Medicine & Obesity Medicine — explains exactly why GLP-1 side effects happen, what’s normal, what’s not, and how to manage them safely without quitting a medication that may be helping you.

You’ll learn:
• Why nausea, reflux, constipation, and fatigue occur on GLP-1 therapy
• Simple nutrition and hydration strategies that reduce symptoms fast
• The most common mistakes patients make that worsen side effects
• When symptoms are normal adaptation vs when to call your clinician
• The truth about thyroid cancer myths and GLP-1 safety

Most GLP-1 side effects are dose-related, temporary, and manageable.
Understanding them correctly can be the difference between stopping early and achieving long-term success.

This module alone prevents thousands of patients from quitting effective therapy too soon.

If you’re currently on Ozempic, Wegovy, Zepbound, Mounjaro, or considering GLP-1 therapy, this is essential medical guidance explained clearly and calmly.

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

Most people quit GLP-1 medications even when they’re working — not because the drug failed, but because their expectations were wrong.

If your GLP-1 weight loss slowed down, stalled, or looks different than expected, this video will reset what normal progress actually looks like.

As a physician board-certified in Internal Medicine and Obesity Medicine, I see this every day:
patients panic during normal plateaus and assume the medication stopped working.

In reality, GLP-1 fat loss is non-linear, biological, and highly individual.

In this short lesson, you’ll learn:

• What realistic GLP-1 weight loss looks like
• When plateaus are normal vs concerning
• Why the scale can mislead early
• Why comparing to others is harmful
• How to know if your medication is actually working

If your hunger is quieter, portions are smaller, and behaviors are improving — your GLP-1 is working.

This module prevents one of the biggest causes of treatment drop-off: misaligned expectations.

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

Muscle loss is one of the strongest predictors of aging, frailty, and early mortality — yet most people focus only on weight, cholesterol, or BMI.

In this evidence-based lecture, Dr. Mohammed Paika — board-certified in Internal Medicine and Obesity Medicine — explains why muscle mass and strength are among the most powerful indicators of longevity, independence, metabolic health, and cognitive function.

After more than two decades caring for patients from the emergency room to the ICU, Dr. Paika has seen a consistent clinical pattern: the patients who remain independent, recover from illness, and live longer are almost always the ones who maintain muscle.

You’ll learn:

• Why muscle predicts lifespan better than weight
• How muscle controls blood sugar and diabetes risk
• The link between muscle loss and frailty
• Why strength prevents falls and disability
• How muscle protects brain health and cognition
• When muscle loss begins (earlier than most think)
• How to build protective muscle at any age
• Practical strength strategies for longevity

Muscle is not just about appearance — it is a biological reserve organ that determines resilience, recovery, and survival with aging.

If you want to maintain independence, metabolic health, and longevity, preserving muscle is essential.

00:00 The #1 Predictor of Longevity
00:42 Why Muscle Predicts Survival
01:40 When Muscle Loss Begins
02:35 Sarcopenia and Mortality Risk
03:40 Muscle and Blood Sugar Control
05:10 Muscle and Metabolic Flexibility
06:35 Muscle Loss and Falls
07:55 Grip Strength and Longevity
09:00 Muscle and Brain Health
10:05 Can You Build Muscle at Any Age?
10:55 Practical Strength for Longevity
11:40 Final Longevity Message

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

In this evidence-based lesson, Dr. Mohammed Paika — board-certified in Internal Medicine and Obesity Medicine — explains how GLP-1 medications actually work in the brain and body to regulate hunger, fullness, and food decision-making.

GLP-1s don’t speed up metabolism.
They don’t burn fat directly.
And they don’t override biology.

They restore disrupted brain–gut signaling that drives chronic hunger in obesity.

When patients understand this, everything changes:
• Why hunger feels quieter
• Why portions feel smaller naturally
• Why weight loss feels easier
• Why this is treatment — not cheating

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.

High blood pressure in obesity is NOT just about salt.

As a hospitalist physician, Dr. Mohammed Paika treats patients with severe hypertension every day — from the emergency room to the ICU. And what’s clear is this: many patients with develop dangerous blood pressure levels even while taking multiple medications.

So what’s really driving hypertension?

In this in-depth evidence-based lecture, Dr. Paika explains the true metabolic causes of high blood pressure — including insulin resistance, visceral fat, RAAS activation, endothelial dysfunction, and processed food exposure.

You’ll learn why salt restriction alone often fails in obesity-related hypertension, how visceral fat alters blood pressure physiology, and why metabolic treatment — including lifestyle and GLP-1 therapy — can improve blood pressure beyond medication alone.

If you or someone you love struggles with obesity, metabolic syndrome, or hypertension, this video explains the biology clearly — without myths, blame, or stigma.

🧠 WHAT YOU’LL LEARN

• The real metabolic cause of hypertension
• Why salt isn’t the main driver in many patients
• How visceral fat raises blood pressure
• Insulin resistance and sodium retention explained
• Why BP medications don’t fix the root cause
• How GLP-1 can improve weight loss improves blood pressure
• The obesity-hypertension physiology doctors see clinically
• Why processed foods worsen hypertension
• How metabolic health lowers BP naturally

⚕️ Medical & Educational Disclaimer

The Dr. Paika Podcast and all related content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information shared is not intended as medical advice and should not be used as a substitute for consultation with your personal physician or qualified healthcare professional.

Listening to this podcast does not create a doctor-patient relationship between you and Dr. Paika.

Health, nutrition, exercise, medication, and weight-management topics discussed may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.

Exercise and lifestyle changes carry inherent risks. By choosing to apply any information from this podcast, you accept full responsibility for your health decisions and outcomes.

Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from the use or application of information presented in this podcast.